John R Stanley
Overview
Explore the profile of John R Stanley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsueh Y, Wang Y, Riding R, Catalano D, Lu Y, Richmond J, et al.
J Invest Dermatol
. 2022 Jul;
142(12):3294-3303.
PMID: 35787400
Despite the central role of IFN-γ in vitiligo pathogenesis, systemic IFN-γ neutralization is an impractical treatment option owing to strong immunosuppression. However, most patients with vitiligo present with <20% affected...
2.
Hammers C, Stanley J
J Invest Dermatol
. 2020 Mar;
140(4):733-741.
PMID: 32200875
For many years, The Journal of Investigative Dermatology (JID) has been a leader in our understanding of many aspects of the major autoimmune blistering skin diseases, pemphigus and bullous pemphigoid....
3.
Ishii K, Yoshida K, Stanley J, Yamagami J, Amagai M, Ishiko A
J Invest Dermatol
. 2020 Mar;
140(10):1919-1926.e7.
PMID: 32142800
Anti-desmoglein (Dsg) 1 and Dsg3 IgG autoantibodies in pemphigus foliaceus and pemphigus vulgaris cause blisters through loss of desmosomal adhesion. It is controversial whether blister formation is due to direct...
4.
Hammers C, Tang H, Chen J, Emtenani S, Zheng Q, Stanley J
J Invest Dermatol
. 2018 May;
138(6):1236-1242.
PMID: 29793618
Identifying previously unknown proteins or detecting the presence of known proteins in research samples is critical to many experiments conducted in life sciences, including dermatology. Sensitive protein detection can help...
5.
Chen J, Zheng Q, Hammers C, Ellebrecht C, Mukherjee E, Tang H, et al.
Cell Rep
. 2017 Jan;
18(1):237-247.
PMID: 28052253
In autoantibody-mediated diseases such as pemphigus, serum antibodies lead to disease. Genetic analysis of B cells has allowed characterization of antibody repertoires in such diseases but would be complemented by...
6.
Yoshida K, Ishii K, Shimizu A, Yokouchi M, Amagai M, Shiraishi K, et al.
J Dermatol Sci
. 2016 Dec;
85(3):197-207.
PMID: 28024684
Background: Pemphigus foliaceus (PF) is an autoimmune blistering disease caused by autoantibodies (Abs) against desmoglein 1 (Dsg1). PF sera contain polyclonal Abs which are heterogeneous mixture of both pathogenic and...
7.
Hammers C, Stanley J
Annu Rev Pathol
. 2016 Feb;
11:175-97.
PMID: 26907530
Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the basal keratinocytes lose adhesion to the...
8.
Kowalczyk A, Rubenstein D, Garrod D, Green K, Stanley J
J Invest Dermatol
. 2016 Feb;
127 Suppl 3:E1.
PMID: 26879533
No abstract available.
9.
Stanley J, Amagai M
J Invest Dermatol
. 2016 Feb;
128 Suppl 3:E16-8.
PMID: 26875735
No abstract available.
10.
Hammers C, Chen J, Lin C, Kacir S, Siegel D, Payne A, et al.
J Invest Dermatol
. 2014 Aug;
135(3):742-749.
PMID: 25142730
Pemphigus vulgaris (PV) is a prototypic tissue-specific autoantibody-mediated disease, in which anti-desmoglein 3 (Dsg3) IgG autoantibodies cause life-threatening blistering. We characterized the autoimmune B-cell response over 14 patient years in...